BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30072683)

  • 1. Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma.
    Yadav DK; Chen W; Bai X; Singh A; Li G; Ma T; Yu X; Xiao Z; Huang B; Liang T
    Ann Transplant; 2018 Aug; 23():524-545. PubMed ID: 30072683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?
    Bhangui P; Allard MA; Vibert E; Cherqui D; Pelletier G; Cunha AS; Guettier C; Vallee JC; Saliba F; Bismuth H; Samuel D; Castaing D; Adam R
    Ann Surg; 2016 Jul; 264(1):155-63. PubMed ID: 26649581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage liver transplantation is a reasonable option for selected patients who have recurrent hepatocellular carcinoma after liver resection.
    Hu Z; Zhou J; Xu X; Li Z; Zhou L; Wu J; Zhang M; Zheng S
    PLoS One; 2012; 7(5):e36587. PubMed ID: 22574187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage liver transplantation for recurrent hepatocellular carcinoma within UCSF criteria after liver resection.
    Liu F; Wei Y; Wang W; Chen K; Yan L; Wen T; Zhao J; Xu M; Li B
    PLoS One; 2012; 7(11):e48932. PubMed ID: 23145027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term outcomes after salvage liver transplantation versus primary liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Zhu Y; Dong J; Wang WL; Li MX; Lu Y
    Transplant Proc; 2013 Nov; 45(9):3329-42. PubMed ID: 24182812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage liver transplantation in the treatment of hepatocellular carcinoma: a meta-analysis.
    Li HY; Wei YG; Yan LN; Li B
    World J Gastroenterol; 2012 May; 18(19):2415-22. PubMed ID: 22654435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of salvage liver transplantation.
    Guerrini GP; Gerunda GE; Montalti R; Ballarin R; Cautero N; De Ruvo N; Spaggiari M; Di Benedetto F
    Liver Int; 2014 Jul; 34(6):e96-e104. PubMed ID: 24517642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-Analysis.
    Murali AR; Patil S; Phillips KT; Voigt MD
    Transplantation; 2017 Aug; 101(8):e249-e257. PubMed ID: 28282359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: feasibility of the Milan criteria and operative risk.
    Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
    Transplant Proc; 2008 Dec; 40(10):3558-61. PubMed ID: 19100437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Transplantation is Equally Effective as a Salvage Therapy for Patients with Hepatocellular Carcinoma Recurrence Following Radiofrequency Ablation or Liver Resection with Curative Intent.
    Muaddi H; Al-Adra DP; Beecroft R; Ghanekar A; Moulton CA; Doyle A; Selzner M; Wei A; McGilvray ID; Gallinger S; Grant DR; Cattral MS; Greig PD; Kachura J; Cleary SP; Sapisochin G
    Ann Surg Oncol; 2018 Apr; 25(4):991-999. PubMed ID: 29327179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milan criteria, University of California, San Francisco, criteria, and model for end-stage liver disease score as predictors of salvage liver transplantation.
    Zhang HM; Jiang WT; Pan C; Deng YL; Zheng H; Shen ZY
    Transplant Proc; 2015 Mar; 47(2):438-44. PubMed ID: 25769587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival comparison between primary transplant and upfront curative treatment with salvage transplant for early stage hepatocellular carcinoma.
    Ng KKC; Cheung TT; Wong TCL; Fung JYY; Dai JWC; Ma KW; She WH; Lo CM
    Asian J Surg; 2019 Feb; 42(2):433-442. PubMed ID: 30262437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harm and Benefits of Salvage Transplantation for Hepatocellular Carcinoma: An Updated Meta-analysis.
    Xiong Q; Geng TT; He L; Gao H
    Transplant Proc; 2016 Dec; 48(10):3336-3347. PubMed ID: 27931579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Liang W; Wu L; Ling X; Schroder PM; Ju W; Wang D; Shang Y; Kong Y; Guo Z; He X
    Liver Transpl; 2012 Oct; 18(10):1226-36. PubMed ID: 22685095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis.
    Lim C; Shinkawa H; Hasegawa K; Bhangui P; Salloum C; Gomez Gavara C; Lahat E; Omichi K; Arita J; Sakamoto Y; Compagnon P; Feray C; Kokudo N; Azoulay D
    Liver Transpl; 2017 Dec; 23(12):1553-1563. PubMed ID: 28945955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma Within or Beyond the Milan Criteria: Comparable Long-Term Outcomes.
    Lee S; Song GW; Kim KW; Kwon JH; Lee SG
    Transplant Proc; 2021; 53(1):92-97. PubMed ID: 33288309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel nomogram for prognosis stratification in salvage liver transplantation: a national-wide study with propensity score matching analysis in China.
    Wang K; Gao F; Dong S; Ding J; Dong L; Shao C; Wang Z; Qiu X; Wei X; Wang Z; Yang J; Xia Q; Zheng S; Xu X
    Hepatobiliary Surg Nutr; 2023 Dec; 12(6):854-867. PubMed ID: 38115922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
    Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
    World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
    Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.